The Preferred Option Sample Clauses

The Preferred Option clause designates a specific choice or course of action as the default or prioritized selection among several alternatives within a contract. In practice, this clause may specify which party's proposal, method, or product will be used unless both parties agree otherwise, or it may outline a hierarchy of options to follow if a decision point arises. Its core function is to streamline decision-making and reduce disputes by clearly establishing which option takes precedence, thereby ensuring efficiency and minimizing ambiguity in contractual performance.
The Preferred Option. A SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis for each of the Short Listed Options was carried out by the key stakeholder’s group. This was supported by site analysis from an architect showing primary views to the sites, information on climate and form, location factors around access and transport, site sketch showing the key building blocks in a possible in situ solution Overall, the non-financial option appraisal process identifies that the preferred non-financial option is option 6d (New build at Tulliallan Primary School) with 739 points, followed by option 6b) (New build at Feregait) with 539 points and option 6c) (New build at Station Road) with 509 points. Option 1 (The “Status Quo”) was placed last in this analysis with 221 points. All options scored considerably higher than Option 1, ‘Do nothing’. In summary, it is possible to conclude that all of the stakeholder groups engaged in this process:  Are likely to support Option 6d) as an overall preferred option, unless something radical changes  Do not support the ‘do nothing’ option in any way  See little difference between the relative merits of options 6b) and 6c). In addition, the outturns appear to provide NHS Fife with both a clearly preferred direction of travel in support of their developing Initial Agreement Document (new build in Kincardine to deliver the developing service model) and site option (Tulliallan Primary School) along with a mandate to further explore / develop Option 6d in the short term subject to the outcomes of formal financial option appraisal.
View Source
The Preferred Option. Service Change Planning Strategic Assessment Initial Agreement Outline Business Case Final BusinessCase Implementation Phase The preferred service delivery option is to continue with the existing arrangement of NHS Lothian contracting with the East Calder Medical Practice to provide General Medical Services to the practice population under the terms of the 2018 GMS Contract. This will include provision of additional GP, Advanced Nurse Practitioner and Practice Nurse sessions. A range of community health services will continue to be provided from the facility including district nursing, health visiting, midwifery and community psychiatric nursing, physiotherapy, podiatry and speech and language therapy. In addition consultant psychiatry clinics and drug and alcohol counselling services will continue to be provided from visiting practitioners. The 2018 General Medical Services Contract in Scotland (GMS 2018) identified a number of priority areas for service redesign. Proposed changes to the workforce will be phased in line with population growth and service model developments and have taken into account the requirements for new roles such as advanced practitioners in physiotherapy, pharmacotherapy and nursing as part of the enhanced primary healthcare team as well as the need to transfer the vaccination programme to community services and to develop community treatment and care (CTAC) services.
View Source
The Preferred Option. The preferred option to be taken forward to Full Business Case is Option 3: New Build on adjacent land, this considers Non-Financial and Financial benefits. This was identified as the preferred option because this is the only option which will accommodate anticipated population growth in the area and enable compliance with DDA requirements. A new build on the land to the rear of the existing building will enable provision to be maintained in an accessible central location, allow for expansion and optimisation of services, and support further integration of health and social care. In addition there would be no requirement to decant the existing facility which is key risk in Options 1 and 2. Consideration of major improvements under Option 2 to address maintenance and statutory standards will not facilitate significant improvements in space utilisation and service provision due to structural and layout constraints. The total Capital cost for Option 3 is £11.483m.
View Source
The Preferred Option. By comparing the pros and cons of the various construction methods, the preferred option is trench excavation by grab dredging by one grab dredger and install the submarine watermain by the “bottom-pull method” followed by protection of the submarine piepeline by backfilling with 4.5m thick armour rock layer with a 0.3m thick grade 75 bedding layer.
View Source
The Preferred Option. As indicated before, Option 4B was proposed initially to be considered as preferred option. But, given the fact that the additional analysis of Option 5 has proven its economic viability and beneficial character for the LWSC this option was finally selected as the preferred option. Under Option 5, a wastewater treatment structure with two WWTPs – New Ngwerere and New Chunga WWTPs will be considered. Manchinchi WWTP including the Garden ponds are proposed to be decommissioned and sold. • Demolition of structures and buildings; • Transport and disposal of construction waste at Chunga landfill; and • Levelling of land. Sale of the excess areas is proposed after completion of the project and is expected to take place over a period from 2019 to 2025.
View Source
The Preferred Option. A SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis for each of the short listed options was carried out by the key stakeholders group. This was supported by site analysis from an architect showing primary views to the sites, information on climate and form, location factors around access and transport, site sketch showing the key building blocks in a possible in situ solution. Indicative Site Plan for New Build at ▇▇▇▇▇▇▇ Street. Overall, the non-financial option appraisal process identifies that the preferred non-financial option is Option 6e (New build at ▇▇▇▇▇▇▇ Street) with 879 points, followed by option 6d (New build at ▇▇▇▇▇ ▇▇▇▇) with 632 points. There is then a gap to the very similarly scoring options 4b (Refurbish ▇▇▇▇▇ ▇▇▇▇) with 435 points; 5c (New build on adjacent car park site) with 431 points and 5d (New build at Lochgelly North School) also with 431 points. Option 1 (The Status Quo) was placed last in this analysis with 256 points. There is thereafter very little to choose between the balance of options, none of which score terribly highly. It is important to note however that all options scored considerably higher than Option 1, ‘Do nothing’ in most variations, with only option 5d) ever scoring less and then only when considering clinical group scoring in isolation. In summary, it is possible to conclude that all of the stakeholder groups engaged in this process:  Are likely to support Option 6e) as an overall preferred option, unless something radical changes.  Do not support the ‘do nothing’ option in any way.  See little difference between the relative merits of options 5b), 5d) and 4b). In addition, the outturns appear to provide NHS Fife with both a clearly preferred direction of travel (new build in Lochgelly to deliver the developing service model) and site option (▇▇▇▇▇▇▇ Street) along with a mandate to further explore/develop Option 6e) in the short term subject to the outcomes of formal financial option appraisal.
View Source

Related to The Preferred Option

  • Convertible Preferred Stock Any Final Redemption Notice shall be given to the holders of record of the shares of Series G Convertible Preferred Stock by telephone line facsimile transmission to such number as shown on the records of the Corporation for such purpose; provided, however, that any failure or defect in the giving of such notice to any such holder shall not affect the validity of notice to or the redemption of shares of Series G Convertible Preferred Stock of any other holder. On the Final Redemption Date (or such later date as a holder of shares of Series G Convertible Preferred Stock surrenders to the Corporation the certificate(s) for shares of Series G Convertible Preferred Stock to be redeemed pursuant to this Section 9(b)), the Corporation shall make payment of the applicable Final Redemption Price to each holder of shares of Series G Convertible Preferred Stock to be redeemed in immediately available funds to such account as specified by such holder in writing to the Corporation at least one Business Day prior to the Final Redemption Date. A holder of shares of Series G Convertible Preferred Stock to be redeemed pursuant to this Section 9(b) shall be entitled to convert in accordance with Section 10 such shares of Series G Convertible Preferred Stock (x) through the day prior to the Final Redemption Date and (y) if the Corporation shall fail to pay the Final Redemption Price of any share of Series G Convertible Preferred Stock when due, at any time after the due date thereof until such date as the Corporation pays the Final Redemption Price of such share of Series G Convertible Preferred Stock to such holder. No share of Series G Convertible Preferred Stock as to which a holder exercises the right of conversion pursuant to Section 10 or the optional redemption right pursuant to Section 11 may be redeemed by the Corporation pursuant to this Section 9(b) on or after the date of exercise of such conversion right or optional redemption right, as the case may be, regardless of whether the Final Redemption Notice shall have been given prior to, on or after the date of exercise of such conversion right or optional redemption right, as the case may be.

  • Series A Preferred Stock The Series A Preferred Stock shall have the following rights, preferences and limitations: i. The Series A Preferred Stock shall have a liquidation preference of $100 per share or an aggregate liquidation preference of $6.4 million. The liquidation preference shall be senior to all other securities of the Company including the Series B, C and D Preferred Stock described below and the Common Stock. ii. The Series A Preferred Stock shall not have specified dividends but shall be entitled to participate on an as-converted basis in any dividends paid on the Common Stock of the Company or the Series B, C or D Preferred Stock. iii. The Series A Preferred Stock shall not be subject to mandatory redemption at the election of the Investors but shall be subject to redemption at a redemption price of $100 per share by the Company at any time on or after ten (10) years after the original date of issuance. iv. The Series A Preferred Stock shall be convertible into shares of Common Stock at a conversion price of $1.00 per share. Each share of Series A Preferred Stock shall be initially convertible into 100 shares of Common Stock based on the $100 liquidation preferential amount thereof. The conversion price and number of shares will be subject to customary anti-dilution adjustments for stock splits, share dividends, recapitalizations, stock issuances, etc., with the anti-dilution adjustment for the issuance of shares at less than the conversion price being determined on the "weighted average method." v. Subject to the provisions of Section 3A hereof, the Series A Preferred Stock, voting as a single class, shall be entitled to elect a majority (4) of the Board of Directors. On all other matters, the holders of the Series A Preferred Stock shall vote together with the holders of the Common Stock and the Series B, C and D Preferred Stock and shall be entitled to cast one vote for each share of Common Stock into which the Series A Preferred Stock is convertible. vi. The approval of the Series A Preferred Stock, voting as a separate class, shall be required for the issuance of any securities having liquidation or other rights senior or superior or equal in any respect to the rights of the Series A Preferred Stock.

  • No Rights to Purchase Preferred Stock The issuance and sale of the Shares as contemplated hereby will not cause any holder of any shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or other rights to purchase capital stock or any other securities of the Company to have any right to acquire any shares of preferred stock of the Company.

  • Series B Preferred Stock 1 Shares.......................................................................1

  • Company Preferred Stock “Company Preferred Stock” shall mean the Preferred Stock, $0.001 par value per share, of the Company.